Oral Abstract Session:
270. Genomics and Susceptibility of Superbugs
Saturday, October 6, 2018: 2:00 PM-3:15 PM
Room: S 157

Tracks: Adult ID, Investigative ID


Moderators:  Jose M. Munita, MD, Clinica Alemana Universidad del Desarrollo and William Miller, MD, UTHealth McGovern Medical School

Presentations:
2:00 PM
Predicting ß-Lactam Resistance using Whole Genome Sequencing (WGS) in Klebsiella pneumoniae: the challenge of ß-lactam inhibitors
Andrea Hujer, BS; Wesley Long, MD; Ph.D; Randall Olsen, MD, PhD; Barry N. Kreiswirth, PhD; Scott R. Evans, PhD; James Musser, MD, PhD; Robert Bonomo, MD
2:30 PM
Multispecies outbreak of KPC-2 producing Enterobacteriaceae in a Chilean pediatric hospital
Laura J Rojas, PhD; Steven H Marshall, MS; Lina M Rivas, MSc.; Maria Spencer, MSc.; Joseph Rutter, BS; Michael R. Jacobs, MD/PhD; Federico Perez, MD, MS; Paulina Coria, MD; Francisca Valdivieso, MD; Rafael Araos Bralic, MD MMSc; Jose M. Munita, MD; Robert A. Bonomo, MD
3:00 PM
Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics-Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data
Sujata M. Bhavnani, Pharm.D., M.S.; Nikolas J. Onufrak, Pharm.D.; Jeffrey P. Hammel, M.S., B.S.; David R. Andes, M.D., FIDSA; John S. Bradley, M.D.; Robert K. Flamm, PhD; Paul G. Ambrose, Pharm.D., FIDSA; Ronald N. Jones, M.D.

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.